Fecal Calprotectin(Stool) at Dr. Essa Lab

Fecal Calprotectin(Stool) at Dr. Essa Lab

The Fecal Calprotectin(Stool) test at Dr. Essa Lab is a highly specialized, non-invasive diagnostic laboratory investigation used to detect and monitor inflammatory activity within the gastrointestinal tract. Calprotectin is a calcium- and zinc-binding protein complex (specifically S100A8/S100A9) found abundantly in the cytoplasm of neutrophil granulocytes, which are a type of white blood cell. When inflammation occurs in the mucosal lining of the intestines, neutrophils rapidly migrate to the site of injury or infection. These cells release calprotectin directly into the intestinal lumen, which is subsequently excreted in the stool. Because calprotectin is highly resistant to enzymatic degradation and remains stable in feces for up to a week at room temperature, it serves as an exceptionally reliable fecal biomarker for organic intestinal inflammation.

At Dr. Essa Lab, utilizing advanced diagnostic technology and automated enzyme-linked immunosorbent assay (ELISA) platforms, the Fecal Calprotectin(Stool) test provides clinicians with precise quantitative measurements of this protein. This test is of paramount clinical importance because it helps healthcare providers differentiate between organic inflammatory bowel diseases (IBD), such as Crohn\’s disease and ulcerative colitis, and functional gastrointestinal disorders like irritable bowel syndrome (IBS), which do not involve mucosal inflammation. By offering a clear diagnostic pathway, this test reduces the need for unnecessary, invasive endoscopic procedures like colonoscopies, while ensuring that patients with active inflammation are quickly identified and directed toward appropriate therapeutic interventions.

The diagnostic value of the Fecal Calprotectin(Stool) test extends beyond initial diagnosis. It is an invaluable tool for monitoring therapeutic response, assessing mucosal healing, and predicting clinical relapses in patients already diagnosed with IBD. The primary benefits of undergoing this test at Dr. Essa Lab include its non-invasive nature, high sensitivity, rapid turnaround time, and the clinical accuracy provided by our experienced pathologists. Common clinical indications for this test include chronic diarrhea, persistent abdominal pain, unexplained weight loss, rectal bleeding, and the monitoring of established inflammatory bowel conditions.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy of your Fecal Calprotectin(Stool) test results at Dr. Essa Lab, patients must adhere to specific preparation guidelines. Proper preparation minimizes the risk of false-positive or false-negative results, allowing our pathologists to deliver precise diagnostic insights. Please follow these instructions carefully:

• Medication Review: Inform your prescribing physician and the laboratory staff of all medications you are currently taking. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, and high-dose aspirin can cause mild, transient intestinal inflammation, leading to falsely elevated calprotectin levels. If clinically permissible, it is generally recommended to discontinue NSAIDs for at least 2 to 7 days prior to sample collection.
• Proton Pump Inhibitors (PPIs): The use of PPIs and other acid-suppressing medications has been associated with mild elevations in fecal calprotectin due to changes in gut flora or subclinical enteropathy. Discuss with your doctor whether you should temporarily pause these medications.
• No Dietary Restrictions: There are no specific dietary restrictions required for this test. You do not need to fast, and you may consume your normal diet prior to sample collection.
• Avoid Contamination: Do not collect the stool sample during active menstruation, or if you have actively bleeding hemorrhoids, as the presence of blood from these sources can interfere with the test results.
• Infection Considerations: If you have recently suffered from an acute viral or bacterial diarrheal illness, it is advisable to wait until the infection has fully resolved before taking the test, as acute infectious colitis will naturally elevate calprotectin levels.

During the Procedure

The Fecal Calprotectin(Stool) test requires the collection of a single stool specimen. Because this is a laboratory-based investigation, the collection process is performed by the patient in the comfort of their home or at a designated collection point at Dr. Essa Lab. The procedure involves the following steps:

• Obtain the Container: Collect a sterile, leak-proof stool collection container provided by Dr. Essa Lab. This container often comes with a small spoon or spatula attached to the lid for easy handling.
• Sample Collection: Defecate into a clean, dry receptacle or onto a clean sheet of plastic wrap placed over the toilet bowl. It is critical that the stool specimen does not come into contact with toilet water, urine, soap, or cleaning chemicals, as these substances can degrade the calprotectin protein and invalidate the test.
• Transferring the Specimen: Using the spatula provided, transfer a small portion of the stool (approximately the size of a walnut, or about 1 to 2 grams) into the sterile container. If the stool is liquid, collect approximately 5 to 10 mL of the fluid.
• Securing and Labeling: Securely tighten the cap of the container to prevent leakage. Label the container clearly with your full name, date of birth, and the exact date and time of collection.
• Submission: Deliver the sample to the nearest Dr. Essa Lab collection center as soon as possible. If immediate delivery is not possible, the sample should be refrigerated (not frozen) and delivered within 24 hours of collection.

When is a Fecal Calprotectin(Stool) Performed?

Differentiating IBD from IBS

Physicians frequently request a Fecal Calprotectin(Stool) test when a patient presents with chronic gastrointestinal symptoms that could indicate either Inflammatory Bowel Disease (IBD) or Irritable Bowel Syndrome (IBS). Because the clinical symptoms of these two conditions overlap significantly—including abdominal pain, bloating, and altered bowel habits—clinical evaluation alone is often insufficient. Calprotectin levels are highly elevated in patients with active IBD due to mucosal inflammation, whereas patients with IBS exhibit normal calprotectin levels. This clear distinction helps clinicians avoid unnecessary colonoscopies in IBS patients while expediting referral for those with true inflammatory pathology.

Monitoring Inflammatory Bowel Disease Activity

For patients with a confirmed diagnosis of Crohn\’s disease or ulcerative colitis, the Fecal Calprotectin(Stool) test is performed at regular intervals to monitor disease activity. Clinical symptoms do not always correlate perfectly with the degree of mucosal inflammation. By measuring calprotectin levels, gastroenterologists can objectively assess whether a patient is in clinical remission or if subclinical inflammation is present. This proactive monitoring allows for timely adjustments in immunosuppressive or biologic therapies, helping to maintain remission and prevent disease flare-ups.

Evaluating Chronic Unexplained Diarrhea

Chronic diarrhea, defined as loose stools lasting for more than four weeks, presents a diagnostic challenge. A Fecal Calprotectin(Stool) test is performed to determine if the underlying cause is inflammatory in nature. Elevated calprotectin levels point toward conditions like microscopic colitis, infectious colitis, or inflammatory bowel disease. Conversely, normal levels suggest non-inflammatory etiologies such as malabsorption syndromes, food intolerances, secretory diarrhea, or functional disorders, guiding the diagnostic pathway in a more targeted direction.

Investigating Persistent Abdominal Pain and Cramping

When a patient experiences persistent, unexplained abdominal pain and cramping, a physician may order a Fecal Calprotectin(Stool) test as part of the initial diagnostic workup. This is especially true when the pain is accompanied by systemic signs such as fever, fatigue, or unexplained weight loss. The test helps determine whether the pain is associated with organic structural damage and inflammation of the intestinal wall, which requires urgent medical intervention, or if it is functional pain that can be managed with dietary and lifestyle modifications.

Assessing Pediatric Gastrointestinal Symptoms

In pediatric medicine, invasive diagnostic procedures like upper and lower endoscopies require general anesthesia and carry inherent risks. Pediatricians frequently utilize the Fecal Calprotectin(Stool) test as a first-line, non-invasive screening tool for children presenting with recurrent abdominal pain, growth failure, or chronic diarrhea. A normal calprotectin level provides reassurance and helps avoid invasive procedures, while an elevated level justifies further diagnostic investigation under anesthesia to confirm conditions like pediatric Crohn\’s disease.

What Does a Fecal Calprotectin(Stool) Detect?

The Fecal Calprotectin(Stool) test is highly sensitive to the presence of neutrophils in the gastrointestinal tract. Consequently, it can detect a wide range of inflammatory, infectious, and structural conditions affecting the intestines. Specifically, this test detects and helps evaluate:

• Active Crohn\’s disease affecting the small intestine or colon
• Active Ulcerative Colitis localized to the colon and rectum
• Infectious colitis caused by bacterial pathogens (e.g., Salmonella, Campylobacter, Clostridioides difficile)
• Infectious colitis caused by parasitic pathogens (e.g., Entamoeba histolytica)
• NSAID-induced enteropathy and mucosal ulceration
• Diverticulitis (inflammation of diverticula in the colon)
• Microscopic colitis (including collagenous and lymphocytic colitis)
• Celiac disease with active mucosal inflammation
• Allergic colitis or food protein-induced enterocolitis in pediatric patients
• Radiation-induced proctitis or enteritis
• Intestinal graft-versus-host disease (GVHD) in post-transplant patients
• Ischemic colitis resulting from compromised blood flow to the bowel
• Colorectal neoplasia or advanced adenomas (which can cause localized inflammatory responses)
• The transition from clinical remission to active flare-up in IBD patients
• The efficacy of anti-inflammatory, immunosuppressive, or biologic therapies
• Mucosal healing following successful therapeutic intervention
• Subclinical inflammation in asymptomatic patients with known gastrointestinal disorders
• The presence of organic intestinal disease as opposed to functional bowel disorders

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Lab is committed to providing rapid, accurate, and reliable diagnostic services. The Fecal Calprotectin(Stool) test is processed using state-of-the-art automated laboratory equipment, ensuring high precision and minimal human error. Typically, the turnaround time for this test is within 24 to 48 hours from the time the specimen is received at our main laboratory facility. Once the analysis is complete, the report is thoroughly reviewed and signed off by our consultant pathologists.

Patients can access their reports conveniently through multiple channels. Dr. Essa Lab offers an online report portal on our official website, where patients can securely download and print their results using their unique lab ID and password. Additionally, reports can be received via WhatsApp or accessed through our mobile application. For patients who prefer physical copies, reports can be collected directly from any of our conveniently located diagnostic centers across Karachi and other cities.

Fecal Calprotectin(Stool) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Calprotectin Concentration	< 50 µg/g	Elevated levels (> 120 µg/g) or borderline levels (50 – 120 µg/g)
Intestinal Mucosa Status	Intact, healthy mucosa with no active neutrophil infiltration	Mucosal inflammation, ulceration, or erosion with neutrophil migration
Inflammatory Activity	Absent or clinically insignificant	Mild, moderate, or severe active inflammation within the GI tract
Diagnostic Probability (IBD)	Very low probability of active Inflammatory Bowel Disease	High probability of active Crohn\’s disease, Ulcerative Colitis, or colitis
Functional vs. Organic Origin	Suggests a functional disorder (e.g., Irritable Bowel Syndrome)	Indicates an organic inflammatory, infectious, or structural pathology
Therapeutic Response	Indicates successful treatment and mucosal healing in known IBD	Indicates ongoing active disease or non-response to current therapy
Relapse Risk Assessment	Low risk of clinical relapse in the immediate future	High risk of imminent clinical relapse in patients in clinical remission

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient\’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Fecal Calprotectin(Stool)?

• Experienced Healthcare Professionals: Our team consists of highly qualified consultant pathologists, microbiologists, and laboratory technologists dedicated to diagnostic excellence.
• Patient-Focused Care: We prioritize patient comfort, confidentiality, and convenience throughout the entire testing process.
• Quality Diagnostic Services: Dr. Essa Lab utilizes state-of-the-art automated equipment and adheres to strict internal and external quality control protocols.
• Professional Reporting: Our reports are comprehensive, easy to understand, and structured to provide clear clinical guidance to your physician.
• Modern Diagnostic Approach: We employ advanced ELISA methodologies to ensure the highest sensitivity and specificity for fecal biomarker testing.
• Comfortable Environment: Our collection centers are designed to provide a clean, hygienic, and welcoming environment for all patients.
• Convenient Locations: With an extensive network of diagnostic centers across Karachi and beyond, accessing our services is simple and hassle-free.
• Commitment to Accurate Diagnosis: We understand the critical role of diagnostic accuracy in patient care and strive to deliver results you and your doctor can trust.